Skip to main content
. 2011 Mar 7;17(9):1174–1179. doi: 10.3748/wjg.v17.i9.1174

Figure 6.

Figure 6

Cumulative incidence of ostomy creation in patients with anorectal stricture. The cumulative incidence of ostomy creation was 38.9%/5 years with infliximab (IFX) (n = 19) and 56.5%/5 years and 83.7%/10 years without IFX (n = 21), respectively.